$RHE
Regional Health Properties Inc

2022 Q4 Form 10-Q Financial Statement

#000095017022025615 Filed on November 22, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $10.16M $11.03M $6.702M
YoY Change 57.71% 64.58% 40.59%
Cost Of Revenue $6.413M $7.476M $2.454M
YoY Change 175.0% 204.65%
Gross Profit $3.742M $3.554M $4.248M
YoY Change -8.89% -16.34%
Gross Profit Margin 36.85% 32.22% 63.38%
Selling, General & Admin $2.705M $4.484M $2.765M
YoY Change -6.04% 62.17% -17.07%
% of Gross Profit 72.29% 126.17% 65.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $585.0K $600.0K $651.0K
YoY Change -8.31% -7.83% -6.2%
% of Gross Profit 15.63% 16.88% 15.32%
Operating Expenses $3.855M $13.00M $6.074M
YoY Change 0.92% 114.04% 46.82%
Operating Profit -$113.0K -$1.971M $628.0K
YoY Change -139.37% -413.85% -0.32%
Interest Expense -$674.0K $564.0K $669.0K
YoY Change 4.17% -15.7% -3.32%
% of Operating Profit 106.53%
Other Income/Expense, Net $1.848M $1.600M -$645.0K
YoY Change -623.51% -348.06% -7.99%
Pretax Income -$2.244M -$371.0K -$17.00K
YoY Change 214.73% 2082.35% -76.06%
Income Tax
% Of Pretax Income
Net Earnings -$4.493M -$371.0K -$39.00K
YoY Change 579.73% 851.28% -46.58%
Net Earnings / Revenue -44.24% -3.36% -0.58%
Basic Earnings Per Share -$1.48 -$1.27
Diluted Earnings Per Share -$2.54 -$1.48 -$21.97K
COMMON SHARES
Basic Shares Outstanding 1.769M 1.769M 1.775M
Diluted Shares Outstanding 1.769M 1.775M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $843.0K $2.373M $6.233M
YoY Change -87.59% -61.93% 34.16%
Cash & Equivalents $800.0K $2.400M $6.200M
Short-Term Investments
Other Short-Term Assets $3.812M $4.275M $4.010M
YoY Change 8.42% 6.61% 14.41%
Inventory
Prepaid Expenses
Receivables $6.289M $6.230M $1.936M
Other Receivables $1.099M $297.0K $383.0K
Total Short-Term Assets $12.04M $13.18M $12.56M
YoY Change -6.02% 4.88% 20.67%
LONG-TERM ASSETS
Property, Plant & Equipment $46.61M $48.51M $50.76M
YoY Change -7.01% -4.43% -42.16%
Goodwill $1.585M $1.585M $1.585M
YoY Change 0.0% 0.0%
Intangibles $12.28M $12.38M $12.82M
YoY Change -3.45% -3.42% -3.31%
Long-Term Investments
YoY Change
Other Assets $0.00 $398.0K $514.0K
YoY Change -100.0% -22.57% -0.58%
Total Long-Term Assets $56.54M $82.25M $94.46M
YoY Change -39.13% -12.93% -5.46%
TOTAL ASSETS
Total Short-Term Assets $12.04M $13.18M $12.56M
Total Long-Term Assets $56.54M $82.25M $94.46M
Total Assets $68.58M $95.43M $107.0M
YoY Change -35.12% -10.84% -3.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.293M $3.478M $3.918M
YoY Change -12.16% -11.23% 33.31%
Accrued Expenses $5.036M $6.854M $4.163M
YoY Change 0.98% 64.64% 81.95%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.329M $10.33M $8.081M
YoY Change -4.66% 27.86% 54.6%
LONG-TERM LIABILITIES
Long-Term Debt $52.18M $52.57M $53.40M
YoY Change -1.32% -1.55% -2.56%
Other Long-Term Liabilities $4.357M $26.63M $34.67M
YoY Change -87.07% -23.2% -9.25%
Total Long-Term Liabilities $52.18M $52.57M $53.40M
YoY Change -1.32% -1.55% -2.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.329M $10.33M $8.081M
Total Long-Term Liabilities $52.18M $52.57M $53.40M
Total Liabilities $64.86M $89.53M $96.15M
YoY Change -31.94% -6.89% -2.12%
SHAREHOLDERS EQUITY
Retained Earnings -$121.4M -$119.2M
YoY Change 6.0%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.716M $5.900M $10.88M
YoY Change
Total Liabilities & Shareholders Equity $68.58M $95.43M $107.0M
YoY Change -35.12% -10.84% -3.0%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$4.493M -$371.0K -$39.00K
YoY Change 579.73% 851.28% -46.58%
Depreciation, Depletion And Amortization $585.0K $600.0K $651.0K
YoY Change -8.31% -7.83% -6.2%
Cash From Operating Activities -$1.425M $627.0K $1.725M
YoY Change -282.23% -63.65% 72.5%
INVESTING ACTIVITIES
Capital Expenditures $98.00K -$31.00K -$45.00K
YoY Change -2550.0% -31.11% -13.46%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$98.00K -$31.00K -$45.00K
YoY Change 2350.0% -31.11% -13.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 35.00K -723.0K -653.0K
YoY Change -106.29% 10.72% 72.3%
NET CHANGE
Cash From Operating Activities -1.425M 627.0K 1.725M
Cash From Investing Activities -98.00K -31.00K -45.00K
Cash From Financing Activities 35.00K -723.0K -653.0K
Net Change In Cash -1.488M -127.0K 1.027M
YoY Change -770.27% -112.37% 80.49%
FREE CASH FLOW
Cash From Operating Activities -$1.425M $627.0K $1.725M
Capital Expenditures $98.00K -$31.00K -$45.00K
Free Cash Flow -$1.523M $658.0K $1.770M
YoY Change -293.77% -62.82% 68.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
rhe Facility Rent Expense
FacilityRentExpense
4919000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.21
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-636000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2013000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2859000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-262000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
241000
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
50000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
46000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
7000
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
us-gaap Interest Expense
InterestExpense
1855000
us-gaap Interest Expense
InterestExpense
2022000
us-gaap Interest Expense
InterestExpense
1855000
us-gaap Interest Expense
InterestExpense
2022000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
146000
dei Entity Address City Or Town
EntityAddressCityOrTown
Suwanee
dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30024
dei City Area Code
CityAreaCode
678
dei Local Phone Number
LocalPhoneNumber
869-5116
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
GA
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q3 us-gaap Security Deposit
SecurityDeposit
398000
dei Entity Registrant Name
EntityRegistrantName
REGIONAL HEALTH PROPERTIES, INC.
CY2021Q4 us-gaap Disposal Group Including Discontinued Operation Accrued Liabilities
DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities
700000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001004724
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33135
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-5166048
dei Entity Address Address Line1
EntityAddressAddressLine1
454 Satellite Boulevard NW
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1768720
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48509000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50127000
CY2022Q3 us-gaap Cash
Cash
2373000
CY2021Q4 us-gaap Cash
Cash
6792000
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
3024000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
3056000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
580000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
177000
CY2022Q3 us-gaap Receivables From Customers
ReceivablesFromCustomers
6230000
CY2021Q4 us-gaap Receivables From Customers
ReceivablesFromCustomers
2145000
CY2022Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
1251000
CY2021Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
460000
CY2022Q3 us-gaap Notes Receivable Net
NotesReceivableNet
297000
CY2021Q4 us-gaap Notes Receivable Net
NotesReceivableNet
362000
CY2022Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2471000
CY2021Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2471000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
22981000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
29909000
CY2022Q3 us-gaap Goodwill
Goodwill
1585000
CY2021Q4 us-gaap Goodwill
Goodwill
1585000
CY2021Q4 us-gaap Security Deposit
SecurityDeposit
398000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1775000
CY2022Q3 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
62642000
CY2021Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
62515000
CY2022Q3 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
6190000
CY2021Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2022Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2021Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
8257000
CY2022Q3 us-gaap Assets
Assets
95425000
CY2021Q4 us-gaap Assets
Assets
105696000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1088000
CY2022Q3 us-gaap Senior Long Term Notes
SeniorLongTermNotes
44887000
CY2021Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
46043000
CY2022Q3 us-gaap Longterm Transition Bond Current And Noncurrent
LongtermTransitionBondCurrentAndNoncurrent
6119000
CY2022Q3 rhe Cost Of Management Fees
CostOfManagementFees
140000
CY2021Q4 us-gaap Longterm Transition Bond Current And Noncurrent
LongtermTransitionBondCurrentAndNoncurrent
6239000
CY2022Q3 us-gaap Other Long Term Debt
OtherLongTermDebt
1562000
CY2021Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
594000
CY2022Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
3478000
CY2021Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
3749000
CY2022Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
6854000
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
4987000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
25258000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
32059000
CY2022Q3 us-gaap Other Liabilities
OtherLiabilities
1367000
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
1629000
CY2022Q3 us-gaap Liabilities
Liabilities
89525000
CY2021Q4 us-gaap Liabilities
Liabilities
95300000
CY2021Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
55000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
55000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1769000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1775000
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1760000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2812000
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2812000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2812000
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2812000
CY2022Q3 us-gaap Preferred Stock Redemption Amount
PreferredStockRedemptionAmount
70288000
CY2021Q4 us-gaap Preferred Stock Redemption Amount
PreferredStockRedemptionAmount
70288000
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
62423000
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
62423000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-119165000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-114542000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
5900000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10396000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
95425000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
105696000
CY2022Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
3000000
CY2021Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
4136000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
10326000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
11980000
CY2022Q3 us-gaap Revenues
Revenues
11030000
CY2021Q3 rhe Cost Of Management Fees
CostOfManagementFees
153000
us-gaap Operating Expenses
OperatingExpenses
29626000
rhe Cost Of Management Fees
CostOfManagementFees
459000
us-gaap Operating Expenses
OperatingExpenses
18057000
rhe Cost Of Management Fees
CostOfManagementFees
468000
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
600000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1971000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
606000
CY2021Q3 us-gaap Revenues
Revenues
6702000
us-gaap Revenues
Revenues
25770000
us-gaap Revenues
Revenues
20251000
CY2022Q3 rhe Patient Care Expense
PatientCareExpense
7476000
CY2021Q3 rhe Patient Care Expense
PatientCareExpense
2454000
rhe Patient Care Expense
PatientCareExpense
14040000
us-gaap Operating Income Loss
OperatingIncomeLoss
-3856000
rhe Patient Care Expense
PatientCareExpense
6911000
CY2022Q3 rhe Facility Rent Expense
FacilityRentExpense
1451000
us-gaap Operating Income Loss
OperatingIncomeLoss
2194000
CY2022Q3 us-gaap Interest Expense
InterestExpense
564000
CY2021Q3 us-gaap Interest Expense
InterestExpense
669000
CY2021Q3 rhe Facility Rent Expense
FacilityRentExpense
1640000
rhe Facility Rent Expense
FacilityRentExpense
4725000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
13001000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
6096000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7269000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.48
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
651000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1819000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1953000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1378000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
980000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3432000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2975000
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1515000
CY2021Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-1000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3742000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
76000
CY2022Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
441000
CY2021Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
219000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1409000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
755000
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
146000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
146000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2164000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-122000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1088000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-839000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1600000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-645000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-767000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2715000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-371000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-39000
us-gaap Net Income Loss
NetIncomeLoss
-4623000
us-gaap Net Income Loss
NetIncomeLoss
-521000
CY2022Q3 rhe Preferred Stock Dividends Undeclared
PreferredStockDividendsUndeclared
2249000
CY2021Q3 rhe Preferred Stock Dividends Undeclared
PreferredStockDividendsUndeclared
2250000
rhe Preferred Stock Dividends Undeclared
PreferredStockDividendsUndeclared
6748000
rhe Preferred Stock Dividends Undeclared
PreferredStockDividendsUndeclared
6748000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2620000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2289000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11371000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-839000
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.48
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.27
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-767000
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.40
CY2021Q1 us-gaap Profit Loss
ProfitLoss
21000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11125000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.40
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.21
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
123000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1769000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1769000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1775000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1775000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1778000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1778000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1728000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1728000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10396000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
111000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-46000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-2927000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7534000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
58000
CY2022Q2 rhe Adjustments To Additional Paid In Capital Forfeitures Of Share Based Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalForfeituresOfShareBasedCompensationRequisiteServicePeriodRecognitionValue
-54000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-1325000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6213000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
58000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-371000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5900000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11104000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-7000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-503000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10738000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
179000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-39000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10878000
us-gaap Profit Loss
ProfitLoss
-4623000
us-gaap Profit Loss
ProfitLoss
-521000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1819000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1953000
us-gaap Share Based Compensation
ShareBasedCompensation
173000
us-gaap Share Based Compensation
ShareBasedCompensation
302000
us-gaap Operating Lease Expense
OperatingLeaseExpense
126000
us-gaap Operating Lease Expense
OperatingLeaseExpense
27000
us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
-1410000
us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
-2150000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
67000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
77000
rhe Noncash Gains Losses On Extinguishment Of Debt
NoncashGainsLossesOnExtinguishmentOfDebt
146000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3742000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
76000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4349000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-758000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-533000
CY2021Q4 us-gaap Replacement Reserve Escrow
ReplacementReserveEscrow
1914000
CY2022Q3 rhe Escrow Deposit Current
EscrowDepositCurrent
530000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2171000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4112000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
183000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
119000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-183000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-119000
CY2021Q4 rhe Escrow Deposit Current
EscrowDepositCurrent
700000
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
1219000
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
1710000
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
882000
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
121000
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
21000
CY2021Q4 us-gaap Goodwill Gross
GoodwillGross
1585000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2097000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1859000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4451000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2134000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9848000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7492000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5397000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9626000
us-gaap Interest Paid Net
InterestPaidNet
1797000
us-gaap Interest Paid Net
InterestPaidNet
2154000
rhe Noncash Payments Of Long Term Debt
NoncashPaymentsOfLongTermDebt
-5044000
rhe Non Cash Debt Issuance Costs And Extinguishment Expenses
NonCashDebtIssuanceCostsAndExtinguishmentExpenses
-102000
rhe Net Payments Through Lender
NetPaymentsThroughLender
-5146000
rhe Noncash Proceeds From Financing
NoncashProceedsFromFinancing
5146000
rhe Non Cash Gain On Ppp Loan Forgiveness
NonCashGainOnPPPLoanForgiveness
229000
rhe Vendor Financed Insurance
VendorFinancedInsurance
1078000
rhe Vendor Financed Insurance
VendorFinancedInsurance
867000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2022Q3 us-gaap Investments
Investments
73000000.0
CY2022Q3 rhe Number Of Health Care Real Estate Properties
NumberOfHealthCareRealEstateProperties
12
CY2022Q3 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
11
CY2022Q3 rhe Number Of Skilled Nursing Facility Operated
NumberOfSkilledNursingFacilityOperated
10
rhe Number Of Assisted Facilities
NumberOfAssistedFacilities
1
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4240000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12713000
CY2021Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
3749000
CY2022Q3 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
317000
CY2021Q4 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
317000
CY2021Q4 us-gaap Goodwill
Goodwill
1585000
CY2022Q3 rhe Finite And Indefinite Lived Intangible Assets Gross
FiniteAndIndefiniteLivedIntangibleAssetsGross
16953000
CY2022Q3 us-gaap Goodwill Gross
GoodwillGross
1585000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4569000
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
3024000
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12384000
CY2022Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
3478000
CY2022Q3 us-gaap Other Liabilities
OtherLiabilities
1400000
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
1600000
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0385
CY2022Q3 us-gaap Goodwill
Goodwill
1585000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
3056000
CY2021Q4 us-gaap Disposal Group Including Discontinued Operation Accounts Payable
DisposalGroupIncludingDiscontinuedOperationAccountsPayable
2500000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5397000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
52000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
71000
CY2022Q3 rhe Antidilutive Securities Excluded From Computation Of Earnings Per Share Intrinsic Value
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareIntrinsicValue
0
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2400000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2200000
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
52600000
CY2022Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1200000
CY2022Q3 rhe Long Term Debt Maturities Repayments Of Principal In Next Twelve Months Subject To Non Default In Payments
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonthsSubjectToNonDefaultInPayments
2900000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
683000
CY2022Q3 us-gaap Cash
Cash
2373000
CY2021Q4 us-gaap Cash
Cash
6792000
CY2022Q3 us-gaap Replacement Reserve Escrow
ReplacementReserveEscrow
2079000
CY2022Q3 rhe Lessee Operating Lease Liability Future Rental Payments
LesseeOperatingLeaseLiabilityFutureRentalPayments
28456000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9848000
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
71398000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
72965000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22889000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22838000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48509000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50127000
CY2022Q3 us-gaap Land Improvements
LandImprovements
100000
CY2022Q3 us-gaap Depreciation
Depreciation
490000
CY2021Q3 us-gaap Depreciation
Depreciation
542000
us-gaap Depreciation
Depreciation
1490000
us-gaap Depreciation
Depreciation
1625000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
110000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
109000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
329000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
328000
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
600000
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
651000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1819000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1953000
CY2022Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
121000
CY2022Q3 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
1115000
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
52568000
CY2022Q3 rhe Lessee Operating Lease Accretion Of Lease Liability
LesseeOperatingLeaseAccretionOfLeaseLiability
3198000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
25258000
CY2022Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2021Q4 rhe Finite And Indefinite Lived Intangible Assets Gross
FiniteAndIndefiniteLivedIntangibleAssetsGross
16953000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates.</span></p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain reclassifications have been made to the amounts in prior periods in order to conform to the current period's presentation.</span></p>
CY2021Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2022Q3 rhe Penalty For Service Contract Non Performance
PenaltyForServiceContractNonPerformance
50000
rhe Percentage Of Additional Allowance For Patient Care Receivables
PercentageOfAdditionalAllowanceForPatientCareReceivables
0.015
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6200000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2100000
CY2022Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
6810000
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2322000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
580000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
177000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6230000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2145000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1300000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
500000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
800000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
109000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
329000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
328000
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0385
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
110000
rhe Operating Leases Number Of Skilled Nursing Facilities Leased
OperatingLeasesNumberOfSkilledNursingFacilitiesLeased
9
rhe Number Of Skilled Nursing Facilities Operated By Third Party Tenants
NumberOfSkilledNursingFacilitiesOperatedByThirdPartyTenants
5
CY2022Q3 rhe Number Of Sublease Agreements Executed Leased By Company
NumberOfSubleaseAgreementsExecutedLeasedByCompany
5
CY2022Q3 rhe Lessee Operating Lease Liability Future Rental Payments Due Year One
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearOne
5465000
CY2022Q3 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year One
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearOne
169000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
5296000
CY2022Q3 rhe Lessee Operating Lease Liability Future Rental Payments Due Year Two
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearTwo
5529000
CY2022Q3 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year Two
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearTwo
354000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5175000
CY2022Q3 rhe Lessee Operating Lease Liability Future Rental Payments Due Year Three
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearThree
5640000
CY2022Q3 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year Three
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearThree
583000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5057000
CY2022Q3 rhe Lessee Operating Lease Liability Future Rental Payments Due Year Four
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearFour
5753000
CY2022Q3 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year Four
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearFour
810000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4943000
CY2022Q3 rhe Lessee Operating Lease Liability Future Rental Payments Due Year Five
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearFive
4987000
CY2022Q3 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year Five
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearFive
883000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
4104000
CY2022Q3 rhe Lessee Operating Lease Liability Future Rental Payments Due After Year Five
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueAfterYearFive
1082000
CY2022Q3 rhe Lessee Operating Lease Accretion Of Lease Liability Due After Year Five
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueAfterYearFive
399000
rhe Number Of Owned Facilities Lessor
NumberOfOwnedFacilitiesLessor
10
rhe Number Of Owned Facilities
NumberOfOwnedFacilities
12
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
rhe Number Of Owned Facilities Sub Lessor
NumberOfOwnedFacilitiesSubLessor
4
rhe Number Of Owned And Leased Out Facilities Lessor
NumberOfOwnedAndLeasedOutFacilitiesLessor
10
rhe Weighted Average Remaining Lease Term Facilities Lessor
WeightedAverageRemainingLeaseTermFacilitiesLessor
P5Y4M24D
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
146000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2164000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-122000
CY2022Q3 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
8402000
CY2022Q3 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
8673000
CY2022Q3 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
8753000
CY2022Q3 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
7863000
CY2022Q3 us-gaap Lessor Operating Lease Payments To Be Received Five Years
LessorOperatingLeasePaymentsToBeReceivedFiveYears
7541000
CY2022Q3 us-gaap Lessor Operating Lease Payments To Be Received Thereafter
LessorOperatingLeasePaymentsToBeReceivedThereafter
7583000
CY2022Q3 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
48815000
CY2022Q3 rhe Accrued Payroll Related Expenses Current
AccruedPayrollRelatedExpensesCurrent
845000
CY2021Q4 rhe Accrued Payroll Related Expenses Current
AccruedPayrollRelatedExpensesCurrent
343000
CY2022Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
2194000
CY2021Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1391000
CY2022Q3 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
109000
CY2021Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
162000
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
202000
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
206000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
192000
CY2022Q3 rhe Medicaid Overpayment Healthcare Services
MedicaidOverpaymentHealthcareServices
1543000
CY2021Q4 rhe Medicaid Overpayment Healthcare Services
MedicaidOverpaymentHealthcareServices
1529000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1961000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1164000
CY2022Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
6854000
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
4987000
CY2022Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
53804000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
54178000
CY2022Q3 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
1115000
CY2021Q4 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
1177000
CY2022Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
121000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
125000
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
52568000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
52876000
CY2022Q3 rhe Debt Instrument Number Of Credit Related Instruments
DebtInstrumentNumberOfCreditRelatedInstruments
16
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1600000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-645000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
2945000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
1929000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
2022000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour
2118000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive
9101000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive
35689000
CY2022Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
53804000
CY2022Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0
CY2021Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0
CY2022Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
3000000
CY2021Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
4136000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
606000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-371000
CY2022Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
13000
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P1Y9M18D
CY2022Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
47.53
CY2022Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
13000
CY2022Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
47.53
CY2022Q3 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
10
CY2022Q3 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
10
CY2022Q3 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
10
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
us-gaap Additional Information About Entitys Reportable Segments
AdditionalInformationAboutEntitysReportableSegments
(i) Real Estate Services, which consists of the leasing and subleasing of long-term care and senior living facilities to third-party tenants, including the Company's management of three facilities on behalf of third-party owners; and (ii) Healthcare Services, which consists of the operation of the LaGrange, Lumber City, Meadowood, Thomasville, Glenvue and Tara Facilities.
CY2022Q3 us-gaap Revenues
Revenues
11030000
CY2021Q3 us-gaap Revenues
Revenues
6702000
CY2022Q3 rhe Patient Care Expense
PatientCareExpense
7476000
CY2021Q3 rhe Patient Care Expense
PatientCareExpense
2454000
CY2022Q3 rhe Facility Rent Expense
FacilityRentExpense
1451000
CY2021Q3 rhe Facility Rent Expense
FacilityRentExpense
1640000
CY2022Q3 rhe Cost Of Management Fees
CostOfManagementFees
140000
CY2021Q3 rhe Cost Of Management Fees
CostOfManagementFees
153000
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
600000
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
651000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1378000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
980000
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1515000
CY2021Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-1000
CY2022Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
441000
CY2021Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
219000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
13001000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
6096000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1971000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2715000
us-gaap Net Income Loss
NetIncomeLoss
-4623000
us-gaap Net Income Loss
NetIncomeLoss
-521000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-39000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
755000
CY2022Q3 us-gaap Interest Expense
InterestExpense
564000
CY2021Q3 us-gaap Interest Expense
InterestExpense
669000
us-gaap Operating Expenses
OperatingExpenses
29626000
us-gaap Operating Expenses
OperatingExpenses
18057000
us-gaap Operating Income Loss
OperatingIncomeLoss
-3856000
us-gaap Operating Income Loss
OperatingIncomeLoss
2194000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
10326000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
11980000
us-gaap Revenues
Revenues
25770000
us-gaap Revenues
Revenues
20251000
rhe Patient Care Expense
PatientCareExpense
14040000
rhe Patient Care Expense
PatientCareExpense
6911000
rhe Facility Rent Expense
FacilityRentExpense
4725000
rhe Facility Rent Expense
FacilityRentExpense
4919000
rhe Cost Of Management Fees
CostOfManagementFees
459000
rhe Cost Of Management Fees
CostOfManagementFees
468000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1819000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1953000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3432000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2975000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3742000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
76000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1409000

Files In Submission

Name View Source Status
0000950170-22-025615-index-headers.html Edgar Link pending
0000950170-22-025615-index.html Edgar Link pending
0000950170-22-025615.txt Edgar Link pending
0000950170-22-025615-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rhe-20220930.htm Edgar Link pending
rhe-20220930.xsd Edgar Link pending
rhe-ex31_1.htm Edgar Link pending
rhe-ex31_2.htm Edgar Link pending
rhe-ex32_1.htm Edgar Link pending
rhe-ex32_2.htm Edgar Link pending
Show.js Edgar Link pending
rhe-20220930_pre.xml Edgar Link unprocessable
rhe-20220930_cal.xml Edgar Link unprocessable
rhe-20220930_lab.xml Edgar Link unprocessable
rhe-20220930_def.xml Edgar Link unprocessable
rhe-20220930_htm.xml Edgar Link completed